I have been eyeing some medtechs lately, and I was pretty interested in Boston Scientific.
Not gonna provide a full DD here, but I like their business for several reasons.
**Management** \--> They seem like a competent mix of results-oriented (strong financial guidance) and learning culture (they invest heavily in investigational devices and let their engineers explore. They also seem to change through organisational design - so actively shaping culture to be more collaborative (Interdependent) rather than siloed (Independent). I also read that they actually try to take care of their employees (to take with a grain of salt, but I am sensitive to positive management).
They also have been buying quite a lot of stock back during the big drawdown (between May and August 2026 - over 2 billion) while managing debt within a safe zone.
**Business** \--> I have a soft spot for mission-critical companies, and like many medtech companies (Intuitive Surgical is another I am watching closely), they are one of them. Their products treat life-threatening conditions (Atrial Fibrillation, Coronary Artery Disease). But they are also not in a maturing phase. They clearly want to expand expertise and reach by strategic acquisitions and consolidating an already dominant position.
**Valuation** \--> Historically, high-moat medtech franchises trade at 20x–25x earnings. A forward P/E of 14 for a company growing organic sales at 7% and adjusted EPS at double digits (15% YoY in Q2) while still growing free and operating cash flow, looks pretty cheap to me.
***Now***, *why I am unsure if I should pull the trigger*. Their latest cyberattack made the stock drop around 10% over the last 2 weeks to reach my price alert; management said that they are unlikely to meet guidance in their next yearly report at the beginning of autumn. Obviously, that statement (which I like they did - pretty transparent) influenced the current drop, but to me it shows that it is extremely unlikely that the company will gain full market confidence until then. Even more, on the day of the financial results - if indeed not met - it could very likely drop further (although probably not crash, since it was announced and predicted early on).
What is your opinion on that? And on the company as a whole